Postmenopausal Vaginal Atrophy  - Market Insights, Epidemiology and Market Forecast-2023

Publisher Name :
Date: 01-Nov-2016
No. of pages: 100
This report is available at upto 40% Discount. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's Postmenopausal Vaginal Atrophy - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Postmenopausal Vaginal Atrophy forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Postmenopausal Vaginal Atrophy till 2023.

Key Coverage and Benefits

- The report will help in developing business strategies by understanding the trends shaping and driving the global Postmenopausal Vaginal Atrophy market.

- Identifying patient populations in the global "Postmenopausal Vaginal Atrophymarket to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the best opportunities for Postmenopausal Vaginal Atrophy therapeutics in each of the markets covered.

- To understand the future market competition in the global Postmenopausal Vaginal Atrophy therapeutics market and Insightful review of the key market drivers and barriers.

Scope

- Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.

- Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.

- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.

- It also provides Postmenopausal Vaginal Atrophy for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

Postmenopausal Vaginal Atrophy  - Market Insights, Epidemiology and Market Forecast-2023

Table of Contents

Postmenopausal Vaginal Atrophyoverview
Pathophysiology
Symptoms of disease
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Drug Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Postmenopausal Vaginal AtrophyMarket
Global Epidemiology of Postmenopausal Vaginal AtrophyForecasted to 2023
Global Market (2013-2015)
Global Forecasted Market (2016-2023)
Global Market by Geography
Market of US (2013-2015)
Forecasted Market of US (2016-2023)
Market of Europe
Market of Germany (2013-2015)
Forecasted Market of Germany (2016-2023)
Market of United Kingdom (2013-2015)
Forecasted Market of United Kingdom (2016-2023)
Market of France (2013-2015)
Forecasted Market of France (2016-2023)
Market of Italy (2013-2015)
Forecasted Market of Italy (2016-2023)
Market of Spain (2013-2015)
Forecasted Market of Spain (2016-2023)
Market of Japan (2013-2015)
Forecasted Market of Japan (2016-2023)
Market of ROW (2013-2015)
Forecasted Market of ROW (2016-2023)
Appendix
Report Methodology
Consulting Services
Disclaimer
Report Purchase Options
About DelveInsight

List of Tables

Table 1:Drug Description
Table 2:Drug, Marketed Details United States (US)
Table 3:Drug, Patent Number Specific Patent Expiry in US (Year), 2015
Table 4:Drug, Patent Details for US
Table 5:Postmenopausal Vaginal AtrophyDrug Sales (USD Millions)-2023
Table 6:Global Epidemiology of Postmenopausal Vaginal Atrophy(2013-2023)
Table 7:Postmenopausal Vaginal AtrophyGlobal Market (USD Millions), (2013-2015)
Table 8:Postmenopausal Vaginal AtrophyGlobal Market (USD Millions), (2016-2023)
Table 9:Postmenopausal Vaginal AtrophyUS Market (USD Millions), (2013-2015)
Table 10: Postmenopausal Vaginal AtrophyUS Market (USD Millions), (2016-2023)
Table 11: Postmenopausal Vaginal AtrophyGermany Market (USD Millions), (2013-2015)
Table 12: Postmenopausal Vaginal AtrophyGermany Market (USD Millions), (2016-2023)
Table 13: Postmenopausal Vaginal AtrophyUnited Kingdom Market (USD Millions), (2013-2015)
Table 14: Postmenopausal Vaginal AtrophyUnited Kingdom Market (USD Millions), (2016-2023)
Table 15: Postmenopausal Vaginal AtrophyFrance Market (USD Millions), (2013-2015)
Table 16: Postmenopausal Vaginal AtrophyFrance Market (USD Millions), (2016-2023)
Table 17: Postmenopausal Vaginal AtrophyItaly Market (USD Millions), (2013-2015)
Table 18: Postmenopausal Vaginal AtrophyItaly Market (USD Millions), (2016-2023)
Table 19: Postmenopausal Vaginal AtrophySpain Market (USD Millions), (2013-2015)
Table 20: Postmenopausal Vaginal AtrophySpain Market (USD Millions), (2016-2023)
Table 21: Postmenopausal Vaginal AtrophyJapan Market (USD Millions), (2013-2015)
Table 22: Postmenopausal Vaginal AtrophyJapan Market (USD Millions), (2016-2023)
Table 23: Postmenopausal Vaginal AtrophyROW Market (USD Millions), (2013-2015)
Table 24: Postmenopausal Vaginal AtrophyROW Market (USD Millions), (2016-2023)

List of Figures

Figure 1: Postmenopausal Vaginal AtrophyDrug Sales (USD Millions)-2023
Figure 2: Global Epidemiology of Postmenopausal Vaginal Atrophy(2013-2023)
Figure 3: Postmenopausal Vaginal AtrophyGlobal Market (USD Millions), (2013-2015)
Figure 4: Postmenopausal Vaginal AtrophyGlobal Market (USD Millions), (2016-2023)
Figure 5: Postmenopausal Vaginal AtrophyUS Market (USD Millions), (2013-2015)
Figure 6: Postmenopausal Vaginal AtrophyUS Market (USD Millions), (2016-2023)
Figure 7: Postmenopausal Vaginal AtrophyGermany Market (USD Millions), (2013-2015)
Figure 8: Postmenopausal Vaginal AtrophyGermany Market (USD Millions), (2016-2023)
Figure 9: Postmenopausal Vaginal AtrophyUnited Kingdom Market (USD Millions), (2013-2015)
Figure 10: Postmenopausal Vaginal AtrophyUnited Kingdom Market (USD Millions), (2016-2023)
Figure 11: Postmenopausal Vaginal AtrophyFrance Market (USD Millions), (2013-2015)
Figure 12: Postmenopausal Vaginal AtrophyFrance Market (USD Millions), (2016-2023)
Figure 13: Postmenopausal Vaginal AtrophyItaly Market (USD Millions), (2013-2015)
Figure 14: Postmenopausal Vaginal AtrophyItaly Market (USD Millions), (2016-2023)
Figure 15: Postmenopausal Vaginal AtrophySpain Market (USD Millions), (2013-2015)
Figure 16: Postmenopausal Vaginal AtrophySpain Market (USD Millions), (2016-2023)
Figure 17: Postmenopausal Vaginal AtrophyJapan Market (USD Millions), (2013-2015)
Figure 18: Postmenopausal Vaginal AtrophyJapan Market (USD Millions), (2015-2023)
Figure 19: Postmenopausal Vaginal AtrophyROW Market (USD Millions), (2013-2015)
Figure 20: Postmenopausal Vaginal AtrophyROW Market (USD Millions), (2016-2023)
  • Global Contraceptives Sales Market Report 2016
    Published: 28-Nov-2016        Price: US 4000 Onwards        Pages: 114
    Notes: Sales, means the sales volume of Contraceptives Revenue, means the sales value of Contraceptives This report studies sales (consumption) of Contraceptives in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - The Female Health Company - Teva Pharmaceutical Industries Ltd. - Reckitt Ben......
  • Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2016
    Published: 16-Nov-2016        Price: US 2000 Onwards        Pages: 52
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2016, provides an overview of the Vaginal Atrophy (Atrophic Vaginitis) (Women's Health) pipeline landscape.Vaginal atrophy is thinning, drying and inflammation of the vaginal walls due to body having less estrogen. Signs and symptoms include vaginal dryness, vaginal discharge, genital itching, burning with urination, and urgency with urination, urinary......
  • Vasomotor Symptoms of Menopause-Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Vasomotor Symptoms of Menopause-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Vasomotor Symptoms of Menopause. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licens......
  • Vulvovaginal Candidiasis-Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Vulvovaginal Candidiasis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Vulvovaginal Candidiasis. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collabora......
  • Dysmenorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
    Published: 01-Nov-2016        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Dysmenorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Dysmenorrhea Report is to understand the market and pipeline status of the drugs around the Dysmenorrhea to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing......
  • Eclampsia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
    Published: 01-Nov-2016        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Eclampsia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Eclampsia Report is to understand the market and pipeline status of the drugs around the Eclampsia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline......
  • Dysmenorrhea-Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Dysmenorrhea-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Dysmenorrhea. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fun......
  • Uterine fibroids - Market Insights, Epidemiology and Market Forecast-2023
    Published: 01-Nov-2016        Price: US 4950 Onwards        Pages: 100
    DelveInsight's Uterine fibroids - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Uterine fibroids forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report ......
  • Endometriosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
    Published: 01-Nov-2016        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Endometriosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Endometriosis Report is to understand the market and pipeline status of the drugs around the Endometriosis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on design......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs